CIRRHOSIS DUE TO HEPATITIS B
Clinical trials for CIRRHOSIS DUE TO HEPATITIS B explained in plain language.
Never miss a new study
Get alerted when new CIRRHOSIS DUE TO HEPATITIS B trials appear
Sign up with your email to follow new studies for CIRRHOSIS DUE TO HEPATITIS B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Common heart drug may hold key to slowing deadly liver disease
Disease control Recruiting nowThis study is testing whether a cholesterol-lowering drug called rosuvastatin can safely slow the progression of liver cirrhosis. It will involve about 256 adults with early-stage cirrhosis who are not yet experiencing severe complications. Participants will take either the drug …
Matched conditions: CIRRHOSIS DUE TO HEPATITIS B
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Quick MRI scan could spot hidden liver cancers ultrasound misses
Diagnosis Recruiting nowThis study is testing if a faster, 20-minute MRI scan without dye is better than the standard ultrasound for finding liver cancer early in people with cirrhosis who are at high risk. Researchers will enroll 300 participants to receive both scans every six months for 30 months to …
Matched conditions: CIRRHOSIS DUE TO HEPATITIS B
Sponsor: University of Oxford • Aim: Diagnosis
Last updated Mar 27, 2026 12:40 UTC